As of 2025-09-18, the EV/EBITDA ratio of Exagen Inc (XGN) is -15.83. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. XGN's latest enterprise value is 194.68 mil USD. XGN's TTM EBITDA according to its financial statements is -12.30 mil USD. Dividing these 2 quantities gives us the above XGN EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 6.7x - 8.6x | 7.8x |
| Forward P/E multiples | 6.2x - 9.1x | 8.0x |
| Fair Price | (3.40) - (4.48) | (4.11) |
| Upside | -137.1% - -148.8% | -144.8% |
| Date | EV/EBITDA |
| 2025-09-17 | -15.83 |
| 2025-09-16 | -15.72 |
| 2025-09-15 | -16.08 |
| 2025-09-12 | -16.85 |
| 2025-09-11 | -17.32 |
| 2025-09-10 | -16.65 |
| 2025-09-09 | -16.96 |
| 2025-09-08 | -16.98 |
| 2025-09-05 | -16.72 |
| 2025-09-04 | -17.01 |
| 2025-09-03 | -16.74 |
| 2025-09-02 | -16.62 |
| 2025-08-29 | -17.06 |
| 2025-08-28 | -16.85 |
| 2025-08-27 | -16.51 |
| 2025-08-26 | -17.14 |
| 2025-08-25 | -17.05 |
| 2025-08-22 | -17.49 |
| 2025-08-21 | -17.28 |
| 2025-08-20 | -17.03 |
| 2025-08-19 | -16.69 |
| 2025-08-18 | -16.87 |
| 2025-08-15 | -16.40 |
| 2025-08-14 | -16.14 |
| 2025-08-13 | -16.72 |
| 2025-08-12 | -16.53 |
| 2025-08-11 | -16.21 |
| 2025-08-08 | -15.88 |
| 2025-08-07 | -15.51 |
| 2025-08-06 | -15.37 |
| 2025-08-05 | -15.29 |
| 2025-08-04 | -15.26 |
| 2025-08-01 | -14.86 |
| 2025-07-31 | -14.45 |
| 2025-07-30 | -14.86 |
| 2025-07-29 | -14.54 |
| 2025-07-28 | -12.65 |
| 2025-07-25 | -12.43 |
| 2025-07-24 | -12.34 |
| 2025-07-23 | -12.52 |
| 2025-07-22 | -11.84 |
| 2025-07-21 | -11.89 |
| 2025-07-18 | -11.95 |
| 2025-07-17 | -12.27 |
| 2025-07-16 | -11.95 |
| 2025-07-15 | -11.56 |
| 2025-07-14 | -12.07 |
| 2025-07-11 | -11.93 |
| 2025-07-10 | -11.95 |
| 2025-07-09 | -11.64 |